Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amber Specialty Pharmacy is a leading U.S. independent specialty pharmacy, offering commercial dispensing of specialty and complex medications, with national accreditation and a reputation for high-touch, patient-centered care for rare, chronic, and complex diseases. As of 2024, it is an award-winning industry leader with nationwide reach and a portfolio including recently FDA-approved medicines such as NEMLUVIO (for prurigo nodularis) and Rezdiffra (for non-alcoholic steatohepatitis).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amber Specialty Pharmacy.